X BOL wishing you a very and Happy New year

Alternative content

Our Sponsors



Download BioinformaticsOnline(BOL) Apps in your chrome browser.




  • Bookmarks
  • Jit
  • GeneProf: analysis of high-throughput sequencing experiment

GeneProf: analysis of high-throughput sequencing experiment

https://www.geneprof.org/GeneProf/index.jsp
GeneProf is a web-based, graphical software suite that allows users to analyse data produced using high-throughput sequencing platforms (RNA-seq and ChIP-seq; "Next-Generation Sequencing" or NGS): Next-gen analysis for next-gen data!

Some of GeneProf's highlights include:

  • Easy-to-use web-based interface:Access your data at any time from any computer with a working internet connection -- no need to install software! (cp. Section 'System Requirements').
  • Analysis wizards make your life easy:Step-by-step workflows make it easy to analyse high-throughput data within a minimum of hands-on time. (cp. SubConcept 'Analysis Wizards').
  • Versatile modules:Advanced users and data analysis experts benefit from GeneProf's broad range of analysis modules, which can be combined freely into sophisticated workflows (cp. Concept 'Workflows').
  • Integrated Analysis:Analysis of ChIP-seq and RNA-seq data in one place, plus support for the integration of other external data (e.g. from microarrays).
  • Comprehensive Resource:GeneProf provides a comprehensive resource of fully analyzed next-generation sequencing data. Experimental results can be easily accessed and compared and the analysis procedures employed to produce the data are fully transparent (cp. Tutorial 'Examining Public Next-Gen Data..').
  • Extensibility:Algorithm developers and computer programmers can develop their own modules and extend GeneProf. Existing software can be easily wrapped in the workflow framework (cp. Section 'Module Development: Adding new..') and data from GeneProf may be used externally (cp. Section 'Web API: Retrieving Data from ..').

 

GeneProf is academic software developed at the Centre for Regenerative Medicine / Institute for Stem Cell ResearchUniversity of Edinburgh and has benefited from funding by the Medical Research Council and the EU Framework 7 Project "EuroSyStem".